Evidence map›Paper›PMID 35352310›Full record

ReviewAdvances in therapy2022

The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours.

Fernando López, Jatin P Shah, Jonathan J Beitler, Carl H Snyderman, Valerie Lund, Cesare Piazza, Antti A Mäkitie, Orlando Guntinas-Lichius, Juan P Rodrigo, Luiz P Kowalski and 9 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advances in therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Update on olfactory neuroblastoma.Virchows Archiv : an international journal of pathology · 2024
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Fernando LópezDepartment of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain. flopez_1981@yahoo.es.ORCID http://orcid.org/0000-0001-7019-9746
Jatin P ShahHead and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Jonathan J BeitlerDepartments of Radiation Oncology, Maine General Hospital, Augusta, Maine, USA.
Carl H SnydermanDepartment of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Valerie LundThe Royal National Throat Nose and Ear Hospital, UCLH Foundation Trust, London, UK.
Cesare PiazzaDepartment of Otorhinolaryngology - Head and Neck Surgery, ASST Spedali Civili di Brescia, University of Brescia, Italy, Brescia, Italy.
Antti A MäkitieDepartment of Otorhinolaryngology, Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Orlando Guntinas-LichiusDepartment of Otorhinolaryngology, Institute of Phoniatry/Pedaudiology, Jena University Hospital, Jena, Germany.
Juan P RodrigoDepartment of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Luiz P KowalskiDepartment of Otorhinolaryngology, Head and Neck Surgery, A.C. Camargo Cancer Center, São Paulo, Brazil.
Miquel QuerDepartment of Otolaryngology, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
Ashok ShahaHead and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Akihiro HommaDepartment of Otolaryngology, Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
Alvaro SanabriaDepartment of Surgery, School of Medicine, Universidad de Antioquia/Hospital Universitario San Vicente Fundación, Medellín, Colombia.
Renata FerrarottoDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Anne W M LeeDepartment of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Victor H F LeeDepartment of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Alessandra RinaldoUniversity of Udine School of Medicine, Udine, Italy.
Alfio FerlitoCoordinator of the International Head and Neck Scientific Group, Padua, Italy.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Endoscopic endonasal surgery has been demonstrated to be effective in the treatment of selected cases of sinonasal cancers. However, in cases of locally advanced neoplasms, as well as recurrences, the most appropriate approach is still debated. The present review aims to summarize the current state of knowledge on the utility of open approaches to resect sinonasal malignant tumours. Published comparative studies and meta-analyses suggest comparable oncological results with lower morbidity for the endoscopic approaches, but selection biases cannot be excluded. After a critical analysis of the available literature, it can be concluded that endoscopic surgery for selected lesions allows for oncologically safe resections with decreased morbidity. However, when endoscopic endonasal surgery is contraindicated and definitive chemoradiotherapy is not appropriate, craniofacial and transfacial approaches remain the best therapeutic option.

Indexed as

Paranasal Sinus NeoplasmsSkull Base NeoplasmsEndoscopyHumansRetrospective StudiesCraniofacial ResectionEndoscopyMaxillectomyParanasal Sinus CancerSinonasal Malignant TumoursSkull Base

Identifiers

PMID35352310
PMCPMC9122878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.